Table 1.
Age (years) | 54 | (45–67) |
---|---|---|
History of breast cancer | 40 | (18%) |
Positive family history | 53 | (24%) |
Referral by breast cancer screening program | 90 | (40%) |
Hormonal status | ||
Premenopausal | 63 | (28%) |
Perimenopausal | 26 | (11%) |
Postmenopausal | 131 | (58%) |
Unknown | 6 | (3%) |
Symptoms | ||
No symptoms | 99 | (44%) |
Pain | 14 | (6%) |
Palpable mass | 60 | (26%) |
Skin abnormality | 11 | (5%) |
Nipple discharge | 42 | (19%) |
Clinical classification | ||
No abnormalities | 114 | (50%) |
Benign | 55 | (24%) |
Uncertain benign | 36 | (16%) |
Uncertain malignant | 21 | (9%) |
Breast density | ||
a.Mostly fatty | 37 | (16%) |
b.Some density (scattered) | 92 | (41%) |
c.Moderately dense (heterogeneous) | 81 | (36%) |
d.Extremely dense | 16 | (7%) |
Indication MBI | ||
BI-RADS 3 lesion | 49 | (22%) |
Discrepancy with clinical findings | 44 | (19%) |
History of breast surgery and equivocal lesion | 24 | (11%) |
Mammography-detected lesion, occult with ultrasound | 63 | (28%) |
MRI-detected lesion, occult with ultrasound | 7 | (3%) |
Nipple discharge and equivocal or negative mammography + ultrasound | 39 | (17%) |
Data are median (IQR) or N (%).